Ausgabe 3/2009
Inhalt (9 Artikel)
Review
Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
Abd A. Tahrani, Milan K. Piya, Anthony H. Barnett
Review
DPP4 inhibitors: from sitagliptin monotherapy to the new alogliptin-pioglitazone combination therapy
Georgia Argyrakopoulou, John Doupis
Review
Teratogenesis associated with antibipolar agents
Ha T. T. Nguyen, Verinder Sharma, Roger S. McIntyre
Review
Optimal treatment of obstructive sleep apnea and excessive sleepiness
Russell Rosenberg, Paul Doghramji
Original Research
Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria
Osvaldo Kohlmann Jr., Alejandro Roca-Cusachs, Stéphane Laurent, Roland E. Schmieder, René R. Wenzel, Roberto Fogari
Original Research
Baseline characteristics of the Indian cohort from the IMPROVE™ study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes
Siddharth Shah, A. K. Das, Ajay Kumar, A. G. Unnikrishnan, Sanjay Kalra, M. P. Baruah, B. Ganapathi, R. K. Sahay
Original Research
The Ex-PRESS glaucoma shunt versus trabeculectomy in open-angle glaucoma: a prospective randomized study
Leo A. M. S. de Jong
Original Research
Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis
Kit N. Simpson, Mary Jane Welch, F. Andrew Kozel, Mark A. Demitrack, Ziad Nahas